04.24.25 -- Why Hire An Interim Chief Medical Officer?

Facing economic pressures, regulatory changes, and technological advancements, learn why CROs must redefine their value propositions and discuss the need for reinvention in 2025.

Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.

If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials.

With over 30 years of proven experience, we provide comprehensive clinical pharmacology services, from data management and analysis to the generation of clinical study reports.

Avance Clinical offers deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications, consistently achieving global regulatory approvals.

Our extensive oncology expertise coupled with an end-to-end approach helps accelerate your clinical programs, giving you the confidence to bring breakthrough treatments to patients.

The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.

Explore how an HRPP serves as the organizational backbone, fostering ethical research practices and the highest levels of participant protection.

Annex 1's impact on sterile manufacturing was dissected at PDA's Dublin workshop. Regulators stressed risk management, centralized control strategies, and the value of personnel knowledge.

This guide to clinical trials explores the regulatory approval, study startup, and trial processes essential for advancing medical innovation.

In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.